Yamagata Michiko, Hiraishi Hideyuki
Department of Gastroenterology, Dokkyo Medical University.
Nihon Rinsho. 2007 Oct;65(10):1749-53.
Helicobacter pylori infection and non-steroidal anti-inflammatory drugs (NSAID) have been accepted as major causes of upper gastrointestinal (GI) ulcers and bleeding. As patients with Helicobacter pylori infection have decreased, upper GI disorders related to NSAID have been relatively increasing. Among patients taking low-dose aspirin, the prevalence of upper GI ulcers is 10-40% and aspirin increases the risk of upper GI bleeding up to 2-fold. Among patients taking nonaspirin NSAID, the prevalence of upper GI ulcers is around 20% and nonaspirin NSAID increases the risk of upper GI bleeding up to 4- to 6-fold. Since the prevalence of GI disorders related to NSAID is very high, endoscopic examination might be considered to monitor GI lesions for patients taking NSAID.
幽门螺杆菌感染和非甾体抗炎药(NSAID)已被公认为上消化道(GI)溃疡和出血的主要原因。随着幽门螺杆菌感染患者数量的减少,与NSAID相关的上消化道疾病相对增多。在服用低剂量阿司匹林的患者中,上消化道溃疡的患病率为10%至40%,阿司匹林使上消化道出血风险增加至2倍。在服用非阿司匹林类NSAID的患者中,上消化道溃疡的患病率约为20%,非阿司匹林类NSAID使上消化道出血风险增加至4至6倍。由于与NSAID相关的胃肠道疾病患病率非常高,对于服用NSAID的患者,可能需要考虑进行内镜检查以监测胃肠道病变。